Home > Journals > Chirurgia > Past Issues > Chirurgia 2017 October;30(5) > Chirurgia 2017 October;30(5):151-9

CURRENT ISSUE
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

CHIRURGIA

A Journal on Surgery


Indexed/Abstracted in: EMBASE, Scopus, Emerging Sources Citation Index

 

REVIEW  


Chirurgia 2017 October;30(5):151-9

DOI: 10.23736/S0394-9508.16.04639-8

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Role of metalloproteinases and their inhibitors in the development of abdominal aortic aneurysm: current insights and systematic review of the literature

Lucia BUTRICO 1, Andrea BARBETTA 1, Salvatore CIRANNI 1, Michele ANDREUCCI 2, Pasquale MASTROROBERTO 3, Stefano DE FRANCISCIS 1, 2, 3, 4, Raffaele SERRA 1, 2, 3, 4

1 Department of Medical and Surgical Sciences, University of Catanzaro, Catanzaro, Italy; 2 Department of Health Sciences, University of Catanzaro, Catanzaro, Italy; 3 Department of Experimental and Clinical Medicine, University of Catanzaro, Catanzaro, Italy; 4 Interuniversity Center of Phlebolymphology (CIFL), International Research and Educational Program in Clinical and Experimental Biotechnology, University Magna Graecia of Catanzaro, Catanzaro, Italy


PDF  


INTRODUCTION: Abdominal aortic aneurysm (AAA) represents a widespread chronic degenerative condition of the aorta, which affects up to 9% of the general population over 65 years of age. Metalloproteinases, that are proteins that are capable to regulate extracellular matrix (ECM) structure and function, are known to play a pivotal role in the degradation of aortic ECM and, then, in the formation of aortic aneurysms.
EVIDENCE ACQUISITION: Medline, Scopus and Science Direct were searched from January 2010 to March 2016 using the key word: “Abdominal aortic aneurysm and MMP,” “Abdominal aortic aneurysm and TIMP,” “Abdominal Aortic Aneurysm and ADAM” and “Abdominal aortic aneurysm and ADAMTS.” We also evaluated the reference lists of retrieved studies to identify studies that had not been identified at first.
EVIDENCE SYNTHESIS: Of the 1917 records found, 316 matched our inclusion criteria. After reading the full-text articles, we decided to exclude 245 manuscripts because of the following reasons: 1) no innovative or important content; 2) no multivariable analysis; 3) insufficient data; 4) no clear potential biases or strategies to solve them; 5) no clear end-points; and 6) inconsistent or arbitrary conclusions. The final set included 71 articles.
CONCLUSIONS: This review explores the three main families of metalloproteinases, Matrix Metalloproteinase (MMP), A Disintegrin and Metalloprotease (ADAM), A disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) and their related tissue inhibitors of metalloproteinases (TIMP), showing their specific role in the field of AAAs.


KEY WORDS: Aortic aneurysm, abdominal - Matrix metalloproteinases - ADAM proteins - ADAMTS proteins - Tissue inhibitor of metalloproteinases

top of page

Publication History

Issue published online: August 28, 2017
Manuscript accepted: November 2, 2016
Manuscript received: August 10, 2016

Cite this article as

Butrico L, Barbetta A, Ciranni S, Andreucci M, Mastroroberto P, De Franciscis S, et al. Role of metalloproteinases and their inhibitors in the development of abdominal aortic aneurysm: current insights and systematic review of the literature. Chirurgia 2017;30:151-9. DOI: 10.23736/S0394-9508.16.04639-8

Corresponding author e-mail

rserra@unicz.it